Dificid Tablet, Film Coated
Product Images NDC 52015-080

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dificid (NDC 52015-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Dificid 01)

FDA Label Image

Principal Display Panel (200 mg Tablet Carton)

This is a description of a drug package for DIFICID tablets, which contain 200 mg of fidaxomicin. The package includes prescribing information and dosage instructions. The tablets also contain several inactive ingredients, and the package lists the drug's National Drug Code (NDC) and storage instructions. The tablets are only available with a prescription and are manufactured by Merck & Co., Inc. in the USA, and by Patheon Inc. in Ontario, Canada. The given number sequences refer to NDC codes and manufacturing numbers, respectively.*

FDA Label Image

Dificid 03

This is a medication called Dificid, which is a fidaxomicin oral suspension. It must be reconstituted by a pharmacist before dispensing. The package contains preparation instructions. This medication is intended for pediatric use and is only for oral administration. Each bottle contains 45 grams of the fidaxomicin active ingredient, mixed with various other inactive ingredients including mixed berry flavoring. Proper storage instructions are provided before and after reconstitution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.